TrialPsychopharmacology2022

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis.

Eef L Theunissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.